ACUVAIL

This brand name is authorized in Canada, Singapore, Turkey, United States

Active ingredients

The drug ACUVAIL contains one active pharmaceutical ingredient (API):

1 Ketorolac UNII 4EVE5946BQ - KETOROLAC TROMETHAMINE

Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration. Read about Ketorolac

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ACUVAIL Ophthalmic solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01BC05	Ketorolac	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02369362
Country: SG	Health Sciences Authority	Identifier(s): 14259P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699490561294
Country: US	FDA, National Drug Code	Identifier(s): 0023-3507